The Mechanism of Pyroptosis and Its Application Prospect in Diabetic Wound Healing
Abdullah Al Mamun,Chuxiao Shao,Peiwu Geng,Shuanghu Wang,Jian Xiao
DOI: https://doi.org/10.2147/jir.s448693
IF: 4.5
2024-03-07
Journal of Inflammation Research
Abstract:Abdullah Al Mamun, 1, 2 Chuxiao Shao, 1 Peiwu Geng, 1 Shuanghu Wang, 1 Jian Xiao 2, 3 1 Central Laboratory of the Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui City, Zhejiang, 323000, People's Republic of China; 2 Molecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325000, People's Republic of China; 3 Department of Wound Healing, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China Correspondence: Jian Xiao, Email Pyroptosis defines a form of pro-inflammatory-dependent programmed cell death triggered by gasdermin proteins, which creates cytoplasmic pores and promotes the activation and accumulation of immune cells by releasing several pro-inflammatory mediators and immunogenic substances upon cell rupture. Pyroptosis comprises canonical (mediated by Caspase-1) and non-canonical (mediated by Caspase-4/5/11) molecular signaling pathways. Numerous studies have explored the contributory roles of inflammasome and pyroptosis in the progression of multiple pathological conditions such as tumors, nerve injury, inflammatory diseases and metabolic disorders. Accumulating evidence indicates that the activation of the NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome results in the activation of pyroptosis and inflammation. Current evidence suggests that pyroptosis-dependent cell death plays a progressive role in the development of diabetic complications including diabetic wound healing (DWH) and diabetic foot ulcers (DFUs). This review presents a brief overview of the molecular mechanisms underlying pyroptosis and addresses the current research on pyroptosis-dependent signaling pathways in the context of DWH. In this review, we also present some prospective therapeutic compounds/agents that can target pyroptotic signaling pathways, which may serve as new strategies for the effective treatment and management of diabetic wounds. Keywords: diabetes mellitus, diabetic wound healing, pyroptosis, NLRP3, caspase-1, GSDMD, inflammation, inflammasome Diabetes mellitus (DM) is a chronic glucose metabolism condition. However, chronic organ and tissue damage from elevated blood glucose levels in DM patients results in the development of retinopathy, nephropathy, neuropathy and diabetic wound healing (DWH). Accumulating evidence indicates that DWH is caused by chronic inflammation due to impaired tissue repair mechanisms in people with DM. 1,2 In addition, diabetic foot ulcers (DFUs) are a severe and common complication of DM that results in significant morbidity and mortality worldwide. 3 Mortality rates associated with the development of DFUs are estimated to be 5% in the first 12 months and 5-year mortality rates have been estimated at 42%. 4 The standard practices in DFU management include surgical debridement, dressings to facilitate a moist wound environment and exudate control, wound off-loading, vascular assessment and infection and glycemic control. 5 Treatment of DFUs accounts for approximately one-third of the total cost of diabetic care, which was estimated to be US $176 billion in direct healthcare expenditures in 2012. 6 Despite these high healthcare costs, about 20% of patients have unhealed DFUs at 1 year. 7 Although there are well-established principles for managing DFUs, the treatment of DFUs is often challenging. A broad spectrum of novel interventions is being studied to improve wound healing. Persistent wounds in DM typically result in chronic inflammatory responses and accumulate several pro-inflammatory mediators. Extensive studies have also indicated that the NLR family pyrin domain containing 3 (NLRP3) inflammasome is activated in patients with DM. 8–10 Inflammasome pathways can be triggered by several metabolic impairments including hyperglycemia, hyperlipidemia and hyperuricemia. 11–14 NACHT domains, leucine-rich repeats (LRRs) and NLRP3 may impair angiogenesis and ulcer healing in T2DM. 15,16 Pyroptosis, a specific type of cell death, functions as a wide-range immune system that defends against pathogenic microbial infections. 17 Numerous studies have shown that excessive pyroptosis can lead to the progression of neurological, cardiovascular and inflammatory diseases. 18–21 Pyroptosis exacerbates metabolic conditions including hyperglycemia by inducing persistent inflammation and insulin-resistant mediators. 22 Moreover, current studies suggest that pyroptosis plays a significant role in developing diabetes complications, particularly in DWH. 23,24 Pyroptosis is an alternative manif -Abstract Truncated-
immunology